Abstract
We aim to investigate the correlations of hypoxia inducible factor-1α (HIF-1α) C1772T (rs11549465) and G1790A (rs11549467) gene polymorphisms with digestive tract cancers. A sum of 267 digestive tract cancers patients were hospitalized in Taizhou Central Hospital of Zhejiang Province as case group between December 2012 and December 2014. Additionally, 275 healthy people who had a physical examination in our hospital at the same time were selected as control group. Polymerase chain reaction-restriction fragment length polymorphism was utilized for detecting allele and genotype frequency of different locus in case and control group. Meta-analysis was performed using Comprehensive Meta-analysis 2.0 (Biostat Inc., Englewood, New Jersey, USA). Our result showed statistical significance only exists in family history of cancer between case and control group (P < 0.05). Both C1772T (rs11549465) and G1790A (rs11549467) polymorphisms showed positive correlations with an increasing risk of digestive tract cancers. The frequencies of TT genotype of C1772T (rs11549465) and GA, AA genotypes of G1790A (rs11549467) polymorphisms in case group were evidently higher compared with the controls (all P < 0.05). Besides, the comparison of allele and dominant models of HIF-1α C1772T (rs11549465) and G1790A (rs11549467) between two groups showed a significant difference (all P < 0.05). Meta-analysis results further confirmed that the onset risk of digestive tract cancers may be improved under allele and dominant models of HIF-1α C1772T (rs11549465) and G1790A (rs11549467) (all P < 0.05). Single nucleotide polymorphisms of HIF-1α C1772T (rs11549465) and G1790A (rs11549467) may play a role in development of digestive tract cancers.
Similar content being viewed by others
References
Agundez JA (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9:520–531
Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruine AP (2010) VHL and HIF signalling in renal cell carcinogenesis. J Pathol 221:125–138
Fransen K, Fenech M, Fredrikson M, Dabrosin C, Soderkvist P (2006) Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45:833–840
He P, Han Q, Liu J, Liu D, Zhao X, Hu T, Jiang L, Dan H, Zeng X, Li J et al (2013) The association between hypoxia-inducible factor-1 alpha gene C1772T polymorphism and cancer risk: a meta-analysis of 37 case-control studies. PLoS One 8:e83441
Hsiao PC, Chen MK, Su SC, Ueng KC, Chen YC, Hsieh YH, Liu YF, Tsai HT, Yang SF (2010) Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 102:163–169
Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T, Kage M (2013) Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer. Int J Clin Oncol 18:293–304
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Kang MJ, Jung SA, Jung JM, Kim SE, Jung HK, Kim TH, Shim KN, Yi SY, Yoo K, Moon IH (2011) Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res 31:575–584
Katicic M, Banic M, Urek MC, Gasparov S, Krznaric Z, Prskalo M, Stimac D, Skrtic A, Vucelic B (2014) Croatian guidelines for gastric cancer prevention by eradication of Helicobacter pylori infection. Lijec Vjesn 136:59–68
Kim YJ, Lee HJ, Kim TM, Eisinger-Mathason TS, Zhang AY, Schmidt B, Karl DL, Nakazawa MS, Park PJ, Simon MC et al (2013) Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1alpha. Int J Cancer 132:29–41
Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D et al (2010) Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog 49:805–809
Li K, Zhang Y, Dan Z, Wang Y, Ren ZC (2009) Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans. Biochem Genet 47:625–634
Li Q, Wang D, Li J, Chen P (2011) Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas. BMC Cancer 11:277
Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ, Ding XF (2005) Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6:155–158
Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z et al (2008) Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99:121–128
M PN (2014) World Medical Association publishes the Revised Declaration of Helsinki. Natl Med J India 27:56
Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40:294–309
Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B, Kumar N (2013) Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol 86:232–250
Qin C, Cao Q, Ju X, Wang M, Meng X, Zhu J, Yan F, Li P, Ding Q, Chen J et al (2012) The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma. Ann Oncol 23:981–989
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104:879–886
Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236–242
Semenza GL (2011) Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 1813:1263–1268
Shieh TM, Chang KW, Tu HF, Shih YH, Ko SY, Chen YC, Liu CJ (2010) Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol 46:e47–e53
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30
Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM (2014) Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer 17:152–160
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620
Wang X, Liu Y, Ren H, Yuan Z, Li S, Sheng J, Zhao T, Chen Y, Liu F, Wang F et al (2011) Polymorphisms in the hypoxia-inducible factor-1alpha gene confer susceptibility to pancreatic cancer. Cancer Biol Ther 12:383–387
Wiener CM, Booth G, Semenza GL (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225:485–488
Wouters BG, Koritzinsky M (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8:851–864
Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL (2009) Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 106:4260–4265
Xu J, Xu L, Li L, You Q, Cha L (2013) HIF-1alpha C1772T polymorphism and gastrointestinal tract cancer risk: a meta-analysis and meta-regression analysis. Genet Test Mol Biomarkers 17:918–925
Yang X, Zhang C, Zhu HC, Qin Q, Zhao LJ, Liu J, Xu LP, Zhang Q, Cai J, Ma JX et al (2014) HIF-1alpha P582S and A588T polymorphisms and digestive system cancer risk-a meta-analysis. Tumour Biol 35:2825–2830
Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1:460–469
Ye Y, Wang M, Hu S, Shi Y, Zhang X, Zhou Y, Zhao C, Wang G, Wen J, Zong H (2014) Hypoxia-inducible factor-1alpha C1772T polymorphism and cancer risk: a meta-analysis including 18,334 subjects. Cancer Invest 32:126–135
Zabaleta J (2012) Multifactorial etiology of gastric cancer. Methods Mol Biol 863:411–435
Zhou Y, Lin L, Wang Y, Jin X, Zhao X, Liu D, Hu T, Jiang L, Dan H, Zeng X et al (2014) The association between hypoxia-inducible factor-1 alpha gene G1790A polymorphism and cancer risk: a meta-analysis of 28 case-control studies. Cancer Cell Int 14:37
Acknowledgments
The authors are grateful to those who gave valuable advices on this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that there no conflicts of interest concerning the publication of this paper.
Ethics statement
The study design was reviewed and approved by the ethics committee of Taizhou Central Hospital of Zhejiang Province. The parents or guardians signed written informed consent at the time of hospitalization to undergo diagnostic and therapeutic procedures. All procedures were conducted according to the Declaration of Helsinki (M 2014).
Rights and permissions
About this article
Cite this article
Ni, ZH., Liang, XJ., Mo, JG. et al. Associations of hypoxia inducible factor-1α gene polymorphisms with susceptibility to digestive tract cancers: a case–control study and meta-analysis. Genes Genom 37, 931–938 (2015). https://doi.org/10.1007/s13258-015-0322-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-015-0322-1